SCHEMBL6096546

SCHEMBL6096546

CC(C)(C)OC(=O)N1CCc2cccc([N+](=O)[O-])c2CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
ESR2 Q92731 1/20 0.48
NR1H2 P55055 1/20 0.47
P2RX3 P56373 1/20 0.46
HPGD P15428 1/20 0.45
UCHL1 P09936 1/20 0.45
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.43
MET P08581 1/20 0.43
AKR1C3 P42330 1/20 0.42
AKR1C1 Q04828 1/20 0.42
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
PARP1 P09874 1/20 0.41
TNKS2 Q9H2K2 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
SCN9A Q15858 1/20 0.41
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17197559 0.93 UCHL1 (0.52) ALDH1A1LMNAMAPTESR2NR1H2
SCHEMBL7025306 0.92 ALDH1A1 (0.47) ALDH1A1LMNAMAPTESR2NR1H2
SCHEMBL6098293 0.86 HPGD (0.48) ALDH1A1MAPTHPGDRAB9AAKR1C3
SCHEMBL4882405 0.84 ESR2 (0.53) ALDH1A1LMNAMAPTESR2NR1H2
SCHEMBL31335753 0.82 DDB1 (0.50) ALDH1A1LMNAMAPTESR2NR1H2
SCHEMBL2129313 0.81 ESR2 (0.53) ESR2NR1H2UCHL1MAPK1PRMT5
SCHEMBL6095657 0.80 HPGD (0.52) ALDH1A1MAPTHPGDRAB9AAKR1C3
SCHEMBL24265583 0.80 ABHD6 (0.53) ESR2NR1H2UCHL1MAPK1PRMT5
SCHEMBL20286648 0.80 NR1H2 (0.54) MAPTESR2NR1H2UCHL1MAPK1
SCHEMBL4880504 0.80 ESR2 (0.53) ALDH1A1LMNAMAPTESR2NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7022694-B2 Indoles and indolines having 5-HT activity PHARMACIA & UPJOHN COMPANY (US) 2006-04-04 US disclosed
EP-1406902-B1 HEXAHYDROAZEPINO[4,5-G]INDOLES AND INDOLINES AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN CO LLC (US) 2005-10-19 EP disclosed
EP-1406902-A1 HEXAHYDROAZEPINO(4,5-G)INDOLES AND INDOLINES AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2004-04-14 EP disclosed
US-20030060458-A1 Indoles and indolines having 5-HT activity PHARMACIA & UPJOHN COMPANY 2003-03-27 US disclosed
WO-2003006466-A1 HEXAHYDROAZEPINO (4, 5-G) INDOLES AND INDOLINES AS 5-HT RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2003-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060458-A1 Indoles and indolines having 5-HT activity TPH1, HTR5A, TPH2 ALDH1A1 479/4885LMNA 4112/4885MAPT 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.